Not applicableUnknownNCT01096225What this trial is testingImmunogenicity Study of S-OIV H1N1 Influenza VaccineWho this might be right forHuman Influenza Chinese Academy of Sciences 20
Testing effectiveness (Phase 2)Study completedNCT00953524What this trial is testingDifferent Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the ElderlyWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 849
Post-approval studies (Phase 4)Study completedNCT01079273What this trial is testingClinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy SubjectsWho this might be right forInfluenza Opera CRO, a TIGERMED Group Company 7
Not applicableStudy completedNCT01037855What this trial is testingObservational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit VaccineWho this might be right forNovel Influenza A (H1N1)A New Flu Virus of Swine Origin Novartis Vaccines 4,028
Early research (Phase 1)Study completedNCT01855945What this trial is testingSafety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.Who this might be right forProphylaxis of A/H3N2v Influenza Novartis Vaccines 627
Large-scale testing (Phase 3)Study completedNCT00971100What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 752
Large-scale testing (Phase 3)Study completedNCT00973349What this trial is testingSafety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly AdultsWho this might be right forInfluenza Novartis 2,719
Testing effectiveness (Phase 2)Study completedNCT00956046What this trial is testingSwine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 MonthsWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 401
Not applicableStudy completedNCT01032980What this trial is testingPost Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and AdultsWho this might be right forInfluenzaSwine-Origin A/H1N1 Influenza Virus Sanofi Pasteur, a Sanofi Company 3,934
Testing effectiveness (Phase 2)Study completedNCT00992212What this trial is testingImmunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10Who this might be right forPandemic Influenza Disease Novartis Vaccines 418
Large-scale testing (Phase 3)Study completedNCT00970177What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 812
Post-approval studies (Phase 4)Study completedNCT01111162What this trial is testingH1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected PatientsWho this might be right forHIV Infections University of Pennsylvania 120
Large-scale testing (Phase 3)Study completedNCT00996138What this trial is testingSingle-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult SubjectsWho this might be right forInfluenza Novartis Vaccines 200
Large-scale testing (Phase 3)UnknownNCT01040078What this trial is testingNovel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 MonthWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Centers for Disease Control and Prevention, China 900
Large-scale testing (Phase 3)Study completedNCT01053143What this trial is testingStudy of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in IndiaWho this might be right forInfluenzaPandemic InfluenzaInfluenza A Virus, H1N1 Subtype Sanofi Pasteur, a Sanofi Company 100
Testing effectiveness (Phase 2)Study completedNCT00992836What this trial is testingSafety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and YouthWho this might be right forHIV InfectionsH1N1 Influenza Virus National Institute of Allergy and Infectious Diseases (NIAID) 155
Testing effectiveness (Phase 2)Study completedNCT00952419What this trial is testingDifferent Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 YearsWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 474
Post-approval studies (Phase 4)Study completedNCT01069367What this trial is testingOpen-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly SubjectsWho this might be right forSwine-Origin Influenza A H1N1 Virus Novartis Vaccines 100
Testing effectiveness (Phase 2)Study completedNCT00954798What this trial is testingSwine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the ElderlyWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 450
Large-scale testing (Phase 3)Study completedNCT00972816What this trial is testingSafety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)Who this might be right forInfluenza Novartis Vaccines 1,357